Revelation Biosciences Inc (REVB) Stock Analysis

Revelation Biosciences Inc (REVB) is a publicly traded company in the HEALTHCARE sector. It trades at $1.06, carries a market capitalization of $4.26M. This page summarizes the public market data, fundamentals, and frequently asked questions for REVB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Revelation Biosciences Inc currently has a Bullish sentiment score of 0.20.

About Revelation Biosciences Inc

Revelation Biosciences Inc. is a clinical-stage biopharmaceutical company headquartered in New York, focused on pioneering immunological diagnostics and therapeutics for disease prevention and treatment. The company leverages innovative research to harness the body's immune responses, aiming to address critical unmet medical needs through its promising product pipeline. As it progresses through clinical trials, Revelation Biosciences stands poised to make impactful contributions to the health...

GNG Research Analysis

GNG Research scores Revelation Biosciences Inc (REVB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for REVB.

Frequently Asked Questions

Does REVB pay dividends?

Revelation Biosciences Inc (REVB) does not currently pay a regular dividend.

What is REVB's market cap?

Revelation Biosciences Inc (REVB) has a market capitalization of $4.26M with a current stock price of $1.06.